Targeting of human squamous carcinomas by SPA470-doxorubicin immunoconjugates

Journal of Drug Targeting

Volumn 11, Issue 2, 2003, Pages 101-107

  Hebert, C ^a   Norris, K ^a   Sauk, J J ^a,b,c  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Doxorubicin; Hsp47 CBP2; Monoclonal antibodies; Squamous carcinoma cells

Indexed keywords

ANTIBODY CONJUGATE; DOXORUBICIN; DOXORUBICIN DERIVATIVE; DOXORUBICIN HYDRAZONE; HEAT SHOCK PROTEIN 47; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY SPA 470; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL KILLING; CELL MUTANT; CELL SURVIVAL; COMPUTER PROGRAM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DILUTION; DRUG BINDING; DRUG EFFICACY; DRUG POTENCY; DRUG TARGETING; FLUORESCENCE ACTIVATED CELL SORTER; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOMA; TARGET CELL;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEAD AND NECK NEOPLASMS; HEAT-SHOCK PROTEINS; HSP47 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOCONJUGATES; TUMOR CELLS, CULTURED;

EID: 0037593546     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1061186031000121478     Document Type: Article

References (38)

1. Adam, M.F., Gabalski, E.C., Block, D.A., Oehlert, J.W., Brown, J.M., Elsaid, A.A., Pinto, H.A. and Terrris, D.J. (1999) "Tissue oxygen distribution in head and neck cancer patients", Head Neck 2, 146-153.
2. Blagosklonny, M.V., An, W.G., Romanova, L.Y., Trepel, J., Fojo, T. and Neckers, L. (1998) "p53 inhibits hypoxia-inducible factor-stimulated transcription", J. Biol. Chem. 273, 11995-11998.
3. Colombatti, M., Nabholz, M., Gros, O. and Bron, C. (1983) "Selective killing of target cells by antibody-ricin A chain or antibody-gelonin hybrid molecules: comparison of cytotoxic potency and use in immunoselection procedures", J. Immunol. 131, 3091-3095.
4. Comerford, K.M., Wallace, T.J., Karhausen, J., Louis, N.A., Montalto, M.C. and Colgan, S.P. (2002) "Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene", Cancer Res. 62, 3387-3394.
5. Dillman, R.O., Shawler, D.L., Johnson, D.E., Meyer, D.L., Koziol, J.A. and Frincke, J.M. (1986) "Preclinical trials with combinations and conjugates of T101 monoclonal antibody and doxorubicin", Cancer Res. 46, 4886-4891.
6. Ellman, G.L. (1959) "Tissue sulfhydryl groups", Arch. Biochem. Biophys. 82, 70-77.
7. Goto, S., Ihara, Y., Arata, Y., Izumi, S., Abe, K., Koji, T. and Kondo, T. (2001) "Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase pi", FASEB J. 15, 2702-2714.
8. Goto, S., Kamada, K., Soh, Y., Ihara, Y. and Kondo, T. (2002) "Significance of nuclear glutathione S-transferase pi in resistance to anti-cancer drugs", Jpn. J. Cancer Res. 93, 1047-1056.
9. Greenfield, R.S., Kaneko, T., Daues, A., Edson, M.A., Fitzgerald, K.A., Olech, L.J., Grattan, J.A., Spitalny, G.L. and Braslawsky, G.R. (1990) "Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker", Cancer Res. 50, 6600-6607.
10. Haddad, J.J. and Land, S.C. (2000) "O(2)-evoked regulation of HIF-1 alpha and NF-kappaB in perinatal lung epithelium requires glutathione biosynthesis", Am. J. Physiol. Lung Cell Mol. Physiol. 278, L492-L503.
11. Haddad, J.J., Olver, R.E. and Land, S.C. (2000) "Antioxidant/pro-oxidant equilibrium regulates HIF-1 alpha and NF-kappaB redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells", J. Biol. Chem. 275, 21130-21139.
12. Hebert, C., Norris, K., Cella-Coletta, R., Reynolds, M., Ordonez, J. and Sauk, J.J. (1999) "Cell surface colligin/Hsp47 associates with tetraspanin protein CD9 in epidermoid carcinoma cell lines", J. Cell Biochem. 73, 248-258.
13. Hu, G., Gura, T., Sabsay, B., Sauk, J., Dixit, S.N. and Veis, A. (1995) "Endoplasmic reticulum protein Hsp47 binds specifically to the N-terminal globular domain of the amino-propeptide of the procollagen I alpha 1 (I)-chain", J. Cell Biochem. 59, 350-367.
14. Kallio, P.J., Wilson, W.J., O'Brien, S., Makino, Y. and Poellinger, L. (1999) "Regulation of the hypoxia-inducible transcription factor 1 alpha by the ubiquitin-proteasome pathway", J. Biol. Chem. 274, 6519-6525.
15. Kaneko, T., Willner, D., Monkovic, I., Knipe, J.O., Braslawsky, G.R., Greenfield, R.S. and Vyas, D.M. (1991) "New hydrazone derivatives of adriamycin and their immunoconjugates - a correlation between acid stability and cytotoxicity", Bioconjug. Chem. 21, 33-41.
16. King, H.D., Dubowchik, G.M., Mastalerz, H., Willner, D., Hofstead, S.J., Firestone, R.A., Lasch, S.J. and Trail, P.A. (2002) "Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: inhibition of aggregation by methoxytriethyleneglycol chains", J. Med. Chem. 45, 4336-4343.
17. Koide, T., Aso, A., Yorihuzi, T. and Nagata, K. (2000) "Conformational requirements of collagenous peptides for recognition by the chaperone protein Hsp47", J. Biol. Chem. 275, 27957-27963.
18. Maitra, A., Iacobuzio-Donahue, C., Rahman, A., Sohn, T.A., Argani, P., Meyer, R., Yeo, C.J., Cameron, J.L., Goggins, M., Kern, S.E., Ashfaq, R., Hruban, R.H. and Wilentz, R.E. (2002) "Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47", Am. J. Clin. Pathol. 118, 52-59.
19. Morino, M., Yasuda, T., Shirakami, T., Kiyosuke, Y., Yoshimura, M., Furusho, T. and Yoshikumi, C. (1994) "HSP47 as a possible marker for malignancy of tumors in vivo", In Vivo 8, 285-288.
20. Morino, M., Tsuzuki, T., Iijima, H., Shirakami, T., Kiyosuke, Y., Ishikawa, Y., Yoshimura, M., Yoshikumi, C. and Saijo, N. (1995) "Marked induction of HSP47, a collagen-binding stress protein, during solid tumor formation of ascitic Sarcoma 180 in vivo", In Vivo 9, 503-508.
21. Morino, M., Tsuzuki, T., Ishikawa, Y., Shirakami, T., Kiyosuke, Y., Yoshimura, M., Matsunaga, K., Yoshikumi, C. and Saijo, N. (1997) "Specific expression of HSP47 in human tumor cell lines in vitro", In Vivo 11, 17-21.
22. Nagata, K., Saga, S. and Yamada, K.M. (1988) "Characterization of a novel transformation-sensitive heat-shock protein (Hsp47) that binds to collagen", Biochem. Biophys. Res. Commun. 153, 428-434.
23. Nandan, D., Ball, E.H. and Sanwal, B.D. (1990) "Two stress proteins of the endoplasmic reticulum bind denatured collagen", Biochem. Cell Biol. 68, 1057-1061.
24. Nikitakis, N.G., Rivera, H., Lopes, M.A., Siavash, H., Reynolds, M.A., Ord, R.A. and Sauk, J.J. (2003) "Immunohistochemical expression of angiogenesis-related markers in oral squamous cell carcinomas with multiple metastatic lymph nodes", Am. J. Clin. Pathol. 119, 574-586.
25. Pak, B.J., Pang, S.C. and Graham, C.H. (1997) "Cellular localization of gp46 at the human fetal-maternal interface", Placenta 18, 477-480.
26. Pastan, I., Willingham, M.C., eds, (1985) "Pathway of endocytosis", Endocytosis (Plenum Publishing Corporation, New York , pp 1-44.
27. Rappa, G., Gamcsik, M.P., Mitina, R.L., Baum, C., Fodstad, O. and Lorico, A. (2003) "Retroviral transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity to L-buthionine-S,R-sulphoximine (BSO): new rationale for the use of BSO in cancer therapy", Eur. J. Cancer 39, 120-128.
28. Sauk, J.J., Norris, K., Hebert, C., Ordonez, J. and Reynolds, M. (1998) "Hsp47 binds to the KDEL receptor and cell surface expression is modulated by cytoplasmic and endosomal pH", Connect. Tissue Res. 37, 105-119.
29. Sauk, J.J., Coletta, R.D., Norris, K. and Hebert, C. (2000) "Binding motifs of CBP2 a potential cell surface target for carcinoma cells", J. Cell Biochem. 78, 251-263.
30. Shirakami, T., Tsuzuki, T., Iijima, H., Ishikawa, Y., Kiyosuke, Y.I., Morino, M., Yoshimura, M. and Yoshikumi, C. (1995) "Inhibition of HSP47 during the transition from solid to ascitic form of Sarcoma 180 in vivo", In Vivo 9, 509-512.
31. Smith, T., Ferreira, L.R., Hebert, C., Norris, K. and Sauk, J.J. (1995) "Hsp47 and cyclophilin B traverse the endoplasmic reticulum with procollagen into pre-golgi intermediate vesicles. A role for Hsp47 and cyclophilin B in the export of procollagen from the endoplasmic reticulum", J. Biol. Chem. 270, 18323-18328.
32. Sutter, C.H., Laughner, E. and Semenza, G.L. (2000) "Hypoxia-inducible factor 1 alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations", Proc. Natl Acad. Sci. USA 97, 4748-4753.
33. Tomida, A. and Tsuruo, T. (1999) "Drug resistance mediated by cellular stress response to the microenvironment of solid tumors", Anticancer Drug Des. (Rev.) 14, 169-177.
34. Trail, P.A., Willner, D., Lasch, S.J., Henderson, A.J., Greenfield, R.S., King, D., Zoeckler, M.E. and Braslawsky, G.R. (1992) "Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models", Cancer Res. 52, 5693-5700.
35. Tritton, T.R. and Yee, G. (1982) "The anticancer agent Adriamycin can be actively cytoxic without entering cells", Science 217, 248-250.
36. Troyano, A., Fernandez, C., Sancho, P., de Blas, E. and Aller, P. (2001) "Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells. The role of intracellular oxidation", J. Biol. Chem. 276, 47107-47115.
37. Tsab, M., Batten, M.R. and Bulleid, N.J. (2000) "Hsp47" a molecular chaperone that interacts with and stabilizes correctly-folded procollagen", EMBO J. 19, 2204-2211.
38. Welkoborsky, H.J., Bernauer, H.S., Riazimand, H.S., Jacob, R., Mann, W.J. and Hinni, M.L. (2000) "Patterns of chromosomal aberrations in metastasizing and nonmetastasizing squamous cell carcinomas of the oropharynx and hypopharynx", Ann. Otol. Rhinol. Laryngol. 109, 401-410.